150 related articles for article (PubMed ID: 11069040)
1. Limitations of the diagnostic criteria for minimally differentiated acute myeloid leukemia (AML-MO).
Iwata H; Kami M; Kishi Y; Oki Y; Tanaka Y; Takeuchi K; Yamazaki I; Suzuki R; Morinaga S; Mutou Y
Leukemia; 2000 Nov; 14(11):2013-4. PubMed ID: 11069040
[No Abstract] [Full Text] [Related]
2. Minimally differentiated acute myeloid leukemia (AML-MO) with lymphoid presentation at relapse: a case report.
Ysebaert L; Carli PM; Casasnovas RO; Girodon F; Caillot D; Mugneret F; Maynadié M
Leukemia; 2001 Oct; 15(10):1673-4. PubMed ID: 11587233
[No Abstract] [Full Text] [Related]
3. CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia treated with idarubicin and cytosine arabinoside.
Handa H; Motohashi S; Isozumi K; Komatsumoto S; Nara M
Acta Haematol; 2002; 108(1):47-52. PubMed ID: 12145468
[TBL] [Abstract][Full Text] [Related]
4. Ph-positive acute lymphoblastic leukemia after long-term remission of Ph-positive acute myeloid leukemia.
Nishida H; Yoshimizu N; Ueno H; Fujita A; Kato T; Park JW; Yano T; Tobinai K; Ikeda Y
Leuk Res; 2007 Mar; 31(3):417-8. PubMed ID: 16730062
[No Abstract] [Full Text] [Related]
5. Multifaceted approach to the diagnosis and classification of acute leukemias.
McKenna RW
Clin Chem; 2000 Aug; 46(8 Pt 2):1252-9. PubMed ID: 10926919
[TBL] [Abstract][Full Text] [Related]
6. Biphenotypic M0 acute myeloid leukemia with trisomy-4.
Keung YK; Kaplan B; Douer D
Leuk Lymphoma; 1994 Jun; 14(1-2):181-4. PubMed ID: 7522717
[TBL] [Abstract][Full Text] [Related]
7. T-cell acute lymphoblastic leukemia relapsing as acute myelogenous leukemia.
Mantadakis E; Danilatou V; Stiakaki E; Paterakis G; Papadhimitriou S; Kalmanti M
Pediatr Blood Cancer; 2007 Mar; 48(3):354-7. PubMed ID: 16206214
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibody anti-MPO is useful in recognizing minimally differentiated acute myeloid leukaemia.
Praxedes MK; De Oliveira LZ; Pereira Wda V; Quintana IZ; Tabak DG; De Oliveira MS
Leuk Lymphoma; 1994 Jan; 12(3-4):233-9. PubMed ID: 8167554
[TBL] [Abstract][Full Text] [Related]
9. Biological profile of 23 cases of minimally differentiated acute myeloid leukemia (AML-M0) and its clinical implications.
Venditti A; Del Poeta G; Stasi R; Buccisano F; Aronica G; Bruno A; Cox C; Maffei L; Tamburini A; Papa G; Amadori S
Blood; 1996 Jan; 87(1):418-20. PubMed ID: 8547674
[No Abstract] [Full Text] [Related]
10. Malignancies of natural killer (NK) cell precursor: myeloid/NK cell precursor acute leukemia and blastic NK cell lymphoma/leukemia.
Suzuki R; Nakamura S
Leuk Res; 1999 Jul; 23(7):615-24. PubMed ID: 10400182
[TBL] [Abstract][Full Text] [Related]
11. [Contribution of immunotyping in the diagnosis and in the prognosis of acute leukemia].
Merle-Béral H; Boucheix C
Rev Prat; 1996 Jan; 46(1):30-6. PubMed ID: 8596888
[TBL] [Abstract][Full Text] [Related]
12. Sequential quantitative MR analysis of bone marrow: differences during treatment of lymphoid versus myeloid leukemia.
Vande Berg BC; Michaux L; Scheiff JM; Malghem J; Lecouvet FE; Bourgois MP; Ferrant A; Michaux JL; Maldague BE
Radiology; 1996 Nov; 201(2):519-23. PubMed ID: 8888252
[TBL] [Abstract][Full Text] [Related]
13. Role of FAB classification of acute leukemias in era of immunophenotyping.
Sachdeva MU; Ahluwalia J; Das R; Varma N; Garewal G
Indian J Pathol Microbiol; 2006 Oct; 49(4):524-7. PubMed ID: 17183842
[TBL] [Abstract][Full Text] [Related]
14. Expression of the hemoglobin scavenger receptor (CD163/HbSR) as immunophenotypic marker of monocytic lineage in acute myeloid leukemia.
Walter RB; Bächli EB; Schaer DJ; Rüegg R; Schoedon G
Blood; 2003 May; 101(9):3755-6. PubMed ID: 12707228
[No Abstract] [Full Text] [Related]
15. Morphology and cytochemistry of acute lymphoblastic leukaemia.
Löffler H; Gassmann W
Baillieres Clin Haematol; 1994 Jun; 7(2):263-72. PubMed ID: 7803901
[TBL] [Abstract][Full Text] [Related]
16. [Diagnostics and therapy of acute myeloid leukemia].
Fritsch S; Metzeler K; Hiddemann W; Buske C
Dtsch Med Wochenschr; 2006 Oct; 131(43):2401-6. PubMed ID: 17054056
[No Abstract] [Full Text] [Related]
17. Dose-reduced induction therapy for acute leukaemias decreases both the complete remission (CR) rate and the probability of leukaemia-free survival (LFS).
Krahl R; Helbig W; Kubel M
Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(6):783-6. PubMed ID: 1713882
[TBL] [Abstract][Full Text] [Related]
18. Differential chemosensitivity of leukemic cells in the myeloid and lymphoid phases of stem cell leukemia (a case report).
Mihál V; Hajdúch M; Dusek J; Jarosová M; Weigl E; Pikalová Z; Indrák K; Safárová M; Janostáková A
Neoplasma; 1997; 44(2):133-6. PubMed ID: 9201294
[TBL] [Abstract][Full Text] [Related]
19. Lineage switch and translocation t(9;11) in acute leukemia.
Van Lierde S; Mecucci C; Casteels-Van Daele M; Van den Berghe H
Am J Pediatr Hematol Oncol; 1989; 11(1):20-2. PubMed ID: 2712237
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometric analysis of cell-surface and intracellular antigens in the diagnosis of acute leukemia.
Paredes-Aguilera R; Romero-Guzman L; Lopez-Santiago N; Burbano-Ceron L; Camacho-Del Monte O; Nieto-Martinez S
Am J Hematol; 2001 Oct; 68(2):69-74. PubMed ID: 11559944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
